Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Nat Commun ; 11(1): 5744, 2020 11 12.
Article in English | MEDLINE | ID: covidwho-922260

ABSTRACT

The world is combating an ongoing COVID-19 pandemic with health-care systems, society and economies impacted in an unprecedented way. It is unclear how many people have contracted the causative coronavirus (SARS-CoV-2) unknowingly and are asymptomatic. Therefore, reported COVID-19 cases do not reflect the true scale of outbreak. Here we present the prevalence and distribution of antibodies to SARS-CoV-2 in a healthy adult population of the Netherlands, which is a highly affected country, using a high-performance immunoassay. Our results indicate that one month into the outbreak (i) the seroprevalence in the Netherlands was 2.7% with substantial regional variation, (ii) the hardest-hit areas showed a seroprevalence of up to 9.5%, (iii) the seroprevalence was sex-independent throughout age groups (18-72 years), and (iv) antibodies were significantly more often present in younger people (18-30 years). Our study provides vital information on the extent of exposure to SARS-CoV-2 in a country where social distancing is in place.


Subject(s)
Antibodies, Viral/blood , Blood Donors/statistics & numerical data , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Adolescent , Adult , Aged , Asymptomatic Diseases/epidemiology , Betacoronavirus/isolation & purification , COVID-19 , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Middle Aged , Netherlands , Pandemics , Prevalence , SARS-CoV-2 , Seroepidemiologic Studies , Social Isolation , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL